{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:35:52Z","timestamp":1790278552898,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T00:00:00Z","timestamp":1423180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0116202","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T22:12:06Z","timestamp":1423260726000},"page":"e0116202","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo"],"prefix":"10.1371","volume":"10","author":[{"given":"Yinghong","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadai","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,2,6]]},"reference":[{"key":"ref1","first-page":"221","article-title":"Advances and challenges in the treatment of glioblastoma: a clinician\u2019s perspective","volume":"15","author":"MM Mrugala","year":"2013","journal-title":"Discov Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrn3060","article-title":"The neurobiology of gliomas: from cell biology to the development of therapeutic approaches","volume":"12","author":"M Westphal","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"831090","DOI":"10.1155\/2012\/831090","article-title":"Impact of temozolomide on immune response during malignant glioma chemotherapy","volume":"2012","author":"S Sengupta","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJM200101113440207","article-title":"Brain tumors","volume":"344","author":"LM DeAngelis","year":"2001","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1200\/JCO.2005.03.089","article-title":"Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis","volume":"23","author":"F Lefranc","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"R Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref8","unstructured":"Brain and Spinal Cord Tumors in Children (2010) American Cancer Society Atlanta, Ga, USA."},{"key":"ref9","unstructured":"National Cancer Institute (2010) FDA Approval for Temozolomide. Available: www.cancer.gov\/cancertopics\/druginfo\/fda-temozolomide<\/ext-link>."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/neuonc\/noq157","article-title":"Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma","volume":"13","author":"JH Sampson","year":"2011","journal-title":"Neuro Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0305-7372(97)90019-0","article-title":"Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials","volume":"23","author":"ES Newlands","year":"1997","journal-title":"Cancer Treat Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e18490","DOI":"10.1371\/journal.pone.0018490","article-title":"Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model","volume":"6","author":"X Wang","year":"2011","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4137\/CMO.S7685","article-title":"Inhibitors of glioma growth that reveal the tumour to the immune system","volume":"5","author":"M Nieto-Sampedro","year":"2011","journal-title":"Clin Med Insights Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1254\/jphs.SC0060164","article-title":"Parthenolide induces apoptosis in glioblastomas without affecting NF-kappaB","volume":"106","author":"KN Anderson","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"ref15","first-page":"E105","article-title":"The solution and solid state stability and excipient compatibility of parthenolide in feverfew","volume":"8","author":"P Jin","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.1021\/jm301064b","article-title":"Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells","volume":"55","author":"Q Zhang","year":"2012","journal-title":"J Med Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"C Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1021\/jo300888s","article-title":"Biomimetic semisynthesis of arglabin from parthenolide","volume":"77","author":"JD Zhai","year":"2012","journal-title":"J Org Chem"},{"key":"ref19","unstructured":"Chen Y, Zhang Q, Zhai JD, Ma WW, Fan HX, Zhang F (2010) W. C. N. Patent 201,010,153,701.0."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11060-004-3010-6","article-title":"Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases","volume":"72","author":"KL1 von Eckardstein","year":"2005","journal-title":"J Neurooncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/jpet.105.097782","article-title":"9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N\u2019-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A","volume":"317","author":"M Guo","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2174\/1389200023337063","article-title":"Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo","volume":"3","author":"MR Feng","year":"2002","journal-title":"Curr Drug Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ddtec.2004.11.014","article-title":"Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models","volume":"1","author":"NJ Abbott","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1073\/pnas.95.10.5724","article-title":"Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases","volume":"95","author":"M Nagane","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000336602","article-title":"Administration of vincristine in a patient with Machado-Joseph disease","volume":"82","author":"A Colpo","year":"2012","journal-title":"Oncology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/neuonc\/nor050","article-title":"Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in rats","volume":"13","author":"B Tyler","year":"2011","journal-title":"Neuro Oncol"},{"key":"ref27","first-page":"6105","article-title":"Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings","volume":"7","author":"D Li","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"G Hudes","year":"2007","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1200\/JCO.2005.66.130","article-title":"Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer","volume":"23","author":"S Chan","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.bmcl.2009.02.080","article-title":"Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives","volume":"19","author":"M Dell\u2019Agli","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1182\/blood-2007-05-090621","article-title":"An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells","volume":"110","author":"ML Guzman","year":"2007","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jcp.22494","article-title":"Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation","volume":"226","author":"Carlisi D","year":"2011","journal-title":"J Cell Physiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.7314\/APJCP.2014.15.12.4897","article-title":"Parthenolide-induced apoptosis, autophagy and suppression of proliferation in HepG2 cells","volume":"15","author":"J Sun","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/jnnp.67.6.763","article-title":"BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy","volume":"67","author":"H Strik","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11060-007-9406-3","article-title":"Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model","volume":"85","author":"S Murphy","year":"2007","journal-title":"J Neurooncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0116202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:28:35Z","timestamp":1540344515000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0116202"}},"subtitle":[],"editor":[{"given":"Guillermo","family":"Velasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,6]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0116202","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,6]]}}}